Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement therapy and affects ~40% of type 1 and type 2 diabetic patients. It increases the risk of death ...
The basis for the prevention of diabetic nephropathy is the treatment of its known risk factors: hypertension, hyperglycemia, smoking, and dyslipidemia. These are also risk factors for ...
Iran: A new study published in the BMC journal Trials is exploring the potential benefits of melatonin supplementation for patients with diabetic chronic kidney disease (CKD). The double-blind, ...
Kidney doctors are called nephrologists. They treat conditions that affect the kidneys, like chronic kidney disease and kidney stones. They also may help people manage chronic conditions like diabetes ...
Researchers evaluated the effects of SGLT2 inhibitors in protecting the kidneys, showing that the drugs might help improve oxygenation in these organs.
Johnson & Johnson's Invokana (canagliflozin) meanwhile also has an indication for diabetic kidney disease, but has been affected by side effect concerns which – while resolved – have sent its ...
A NEW study highlights the potential benefits of sodium-glucose cotransporter 2 inhibitors (SGLT-2i) in diabetic kidney transplant recipients (KTR), showing significant reductions in mortality and ...